← All Sponsors
SPONSOR

NorthSea Therapeutics B.V.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Intestinal Failure Associated Liver Disease
NCT05919680 Phase 2
Recruiting

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

Intestinal Failure Associated Liver Disease
United States View Trial →